Research on the A549 cell apoptosis mechanism of the nude mouse model using MenSC-sTRAIL

H Ding1, J Wang, F-P Jia

  • 1Department of Respiratory Diseases, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China. wangjian160908@163.com.

Abstract

Insights

MenSC-sTRAIL effectively induces apoptosis in lung cancer A549 cells within a nude mouse model. This therapy impacts the Bcl-2/Bax protein balance, promoting programmed cell death in cancer cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Targeted therapies are crucial for improving treatment outcomes.
  • Understanding apoptosis-inducing mechanisms is key for novel therapeutic development.

Purpose of the Study:

  • To evaluate the anti-cancer effects of MenSC-sTRAIL on A549 lung cancer cells.
  • To investigate the molecular mechanisms underlying MenSC-sTRAIL-induced apoptosis.
  • To assess MenSC-sTRAIL efficacy in a preclinical nude mouse model.

Main Methods:

  • Tumor growth kinetics were monitored in A549 cell xenografts in nude mice.
  • Cellular apoptosis was quantified using flow cytometry with Annexin V-FITC staining.
  • Western blot analysis was employed to measure Bax protein expression levels.

Main Results:

  • MenSC-sTRAIL significantly promoted apoptosis in A549 lung cancer cells.
  • Quantitative assays confirmed MenSC-sTRAIL's role in inducing cellular apoptosis.
  • Western blot analysis revealed that MenSC-sTRAIL upregulates the expression of the pro-apoptotic protein Bax.

Conclusions:

  • MenSC-sTRAIL demonstrates potential as an apoptosis-inducing agent for lung cancer.
  • The mechanism involves modulating the Bcl-2/Bax heterodimer balance, favoring apoptosis.
  • Further research into MenSC-sTRAIL could lead to new lung cancer treatment strategies.